C07C 217/52
Compounds containing amino and etherified hydroxy groups bound to the same carbon
Official title: having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
C07C217/52 (Compounds containing amino and etherified hydroxy groups bound to the same carbon) appears on 134 US grants and 111 published applications in this corpus.
Search patents in C07C- Granted patents
- 134
- Published applications
- 111
- Assignees
- 92
- Inventors
- 495
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 8 | 0 |
| 1999 | 7 | 0 |
| 2000 | 6 | 0 |
| 2001 | 3 | 1 |
| 2002 | 5 | 5 |
| 2003 | 3 | 5 |
| 2004 | 3 | 1 |
| 2005 | 5 | 10 |
| 2006 | 1 | 2 |
| 2007 | 5 | 4 |
| 2008 | 2 | 2 |
| 2009 | 2 | 7 |
| 2010 | 2 | 7 |
| 2011 | 4 | 6 |
| 2012 | 2 | 1 |
| 2013 | 3 | 8 |
| 2014 | 5 | 6 |
| 2015 | 8 | 8 |
| 2016 | 5 | 7 |
| 2017 | 8 | 3 |
| 2018 | 2 | 4 |
| 2019 | 4 | 5 |
| 2020 | 5 | 3 |
| 2021 | 2 | 0 |
| 2022 | 1 | 5 |
| 2023 | 2 | 1 |
| 2024 | 3 | 5 |
| 2025 | 1 | 3 |
| 2026 | 2 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors26 May 2026US 12,636,266 B2Rivo Bio, Inc.
- Non-coordinating anion activators containing a cation with long chain alkoxy functionalization12 May 2026US 12,623,997 B2ExxonMobil Chemical Patents Inc.
- Dimethoxyphenylalkylamine activators of serotonin receptors8 Jul 2025US 12,351,537 B2Atai Therapeutics, Inc.
- Compounds for modulating mitochondrial function25 Jun 2024US 12,017,992 B2Mayo Foundation for Medical Education and Research
- Dimethoxyphenylalkylamine activators of serotonin receptors12 Mar 2024US 11,926,574 B2Atai Therapeutics, Inc.
- Cyclohexyl or heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia17 Sep 2026US 2026/0274785 A1Atrogi AB
- Non-coordinating anion activators containing a cation with long chain alkoxy functionalization13 Aug 2026US 2026/0234097 A1ExxonMobil Chemical Patents Inc.
- 5-methoxymethyl and 5-hydroxymethyl phenethylamines20 Nov 2025US 2025/0353808 A12A Biosciences, Inc.
- Dimethoxyphenylalkylamine activators of serotonin receptors11 Sep 2025US 2025/0282712 A1Atai Therapeutics, Inc.
- Indane-, indene-, azaindane-, and azaindene-amines as activators of serotonin receptors17 Jul 2025US 2025/0228798 A1Rivo Bio, Inc.
Most cited
By later US patents
- 1-phenyl-2-dimenthylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients95US 5,801,201 AGruenenthal GmbH · 1998
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives68US 5,877,218 ATeva Pharmaceutical Industries Ltd. · 1999
- Cycloalkyl tachykinin receptor antagonists44US 5,750,549 AMerck & Co., Inc. · 1998
- 2-aminoindans as selective dopamine D3 ligands32US 5,708,018 APharmacia & Upjohn Company · 1998